Brief: Genscript Biotech' Unit Submits NDA To Japanese Ministry Of Health, Labour And Welfare
Dec 6 (Reuters) - Genscript Biotech Corp 1548.HK :
* UNIT SUBMITS NEW DRUG APPLICATION TO JAPANESE MINISTRY OF
HEALTH, LABOUR AND WELFARE FOR CILTACABTAGENE AUTOLEUCEL
* CILTA-CEL FOR TREATMENT OF ADULTS WITH RELAPSED OR
REFRACTORY
MULTIPLE MYELOMA
Source text for Eikon: ID:nHKS2mqkmB
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale